Recent Finacing
Recent Raise
Dilafor AB develops tafoxiparin, a modified heparin heparan sulfate mimetic delivered subcutaneously to promote cervical ripening and shorten slow or protracted labor, currently in Phase II development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
